Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/152378
Title: | High Prevalence of Strongyloidiasis in Spain: A Hospital-Based Study |
Author: | Requena-Méndez, Ana Salas-Coronas, Joaquín Salvador, Fernando Gómez Junyent, Joan Villar Garcia, Judith Santín Cerezales, Miguel Muñoz, Carmen González Cordón, Ana Cabezas Fernández, Maria Teresa Sulleiro, Elena Arenas-Miras, Maria del Mar Somoza, Dolors Vazquez Villegas, Jose Treviño, Begoña Rodríguez de las Parras, Esperanza Valls, M. Eugenia Llaberia Marcual, Jaume Subirà, Carme Muñoz, José |
Keywords: | Nematodes Malalties parasitàries Nematodes Parasitic diseases |
Issue Date: | 11-Feb-2020 |
Publisher: | MDPI |
Abstract: | Introduction: Strongyloidiasis is a prevailing helminth infection ubiquitous in tropical and subtropical areas, however, seroprevalence data are scarce in migrant populations, particularly for those coming for Asia. Methods: This study aims at evaluating the prevalence of S. stercoralis at the hospital level in migrant populations or long term travellers being attended in out-patient and in-patient units as part of a systematic screening implemented in six Spanish hospitals. A cross-sectional study was conducted and systematic screening for S. stercoralis infection using serological tests was offered to all eligible participants. Results: The overall seroprevalence of S. stercoralis was 9.04% (95%CI 7.76–10.31). The seroprevalence of people with a risk of infection acquired in Africa and Latin America was 9.35% (95%CI 7.01–11.69), 9.22% (7.5–10.93), respectively. The number of individuals coming from Asian countries was significantly smaller and the overall prevalence in these countries was 2.9% (95%CI −0.3–6.2). The seroprevalence in units attending potentially immunosuppressed patients was significantly lower (5.64%) compared with other units of the hospital (10.20%) or Tropical diseases units (13.33%) (p < 0.001). Conclusions: We report a hospital-based strongyloidiasis seroprevalence of almost 10% in a mobile population coming from endemic areas suggesting the need of implementing strongyloidiasis screening in hospitalized patients coming from endemic areas, particularly if they are at risk of immunosuppression. |
Note: | Reproducció del document publicat a: http://dx.doi.org/10.3390/pathogens9020107 |
It is part of: | Pathogens, 2020, vol. 9, num. 2 |
URI: | http://hdl.handle.net/2445/152378 |
Related resource: | http://dx.doi.org/10.3390/pathogens9020107 |
ISSN: | 2076-0817 |
Appears in Collections: | Articles publicats en revistes (ISGlobal) Articles publicats en revistes (Medicina) Articles publicats en revistes (Ciències Clíniques) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Requena-MendezA_Pathogens_2020.pdf | 729.85 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License